Literature DB >> 23932899

Molecular diagnostics for the detection of Bokeloh bat lyssavirus in a bat from Bavaria, Germany.

Conrad M Freuling1, Björn Abendroth, Martin Beer, Melina Fischer, Dennis Hanke, Bernd Hoffmann, Dirk Höper, Frank Just, Thomas C Mettenleiter, Juliane Schatz, Thomas Müller.   

Abstract

A brain sample of a Natterer's bat tested positive for rabies with classical virological techniques. Molecular techniques confirmed the presence of Bokeloh bat lyssavirus (BBLV) in Germany for the second time. Sequence analysis revealed a close genetic relationship to the initial German BBLV case. Using a TaqMan RT-PCR specific for BBLV viral RNA was detected in various other organs albeit with differences in the relative viral load.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bat rabies; Bokeloh bat lyssavirus; Lyssaviruses; Microarray; Myotis nattereri; Realtime PCR

Mesh：

Year:  2013        PMID： 23932899     DOI： 10.1016/j.virusres.2013.07.021

Source DB:  PubMed          Journal:  Virus Res        ISSN： 0168-1702            Impact factor:   3.303


  13 in total

Review 1.  Molecular, ecological, and behavioral drivers of the bat-virus relationship.

Authors:  Victoria Gonzalez; Arinjay Banerjee
Journal:  iScience       Date:  2022-07-20

2.  Twenty years of active bat rabies surveillance in Germany: a detailed analysis and future perspectives.

Authors:  J Schatz; B Ohlendorf; P Busse; G Pelz; D Dolch; J Teubner; J A Encarnação; R-U Mühle; M Fischer; B Hoffmann; L Kwasnitschka; A Balkema-Buschmann; T C Mettenleiter; T Müller; C M Freuling
Journal:  Epidemiol Infect       Date:  2013-09-06       Impact factor: 4.434

Review 3.  European bats as carriers of viruses with zoonotic potential.

Authors:  Claudia Kohl; Andreas Kurth
Journal:  Viruses       Date:  2014-08-13       Impact factor: 5.048

4.  Enhanced passive bat rabies surveillance in indigenous bat species from Germany--a retrospective study.

Authors:  Juliane Schatz; Conrad Martin Freuling; Ernst Auer; Hooman Goharriz; Christine Harbusch; Nicholas Johnson; Ingrid Kaipf; Thomas Christoph Mettenleiter; Kristin Mühldorfer; Ralf-Udo Mühle; Bernd Ohlendorf; Bärbel Pott-Dörfer; Julia Prüger; Hanan Sheikh Ali; Dagmar Stiefel; Jens Teubner; Rainer Günter Ulrich; Gudrun Wibbelt; Thomas Müller
Journal:  PLoS Negl Trop Dis       Date:  2014-05-01

Review 5.  Bat-man disease transmission: zoonotic pathogens from wildlife reservoirs to human populations.

Authors:  N Allocati; A G Petrucci; P Di Giovanni; M Masulli; C Di Ilio; V De Laurenzi
Journal:  Cell Death Discov       Date:  2016-06-27

6.  Bat rabies surveillance in France: first report of unusual mortality among serotine bats.

Authors:  Evelyne Picard-Meyer; Alexandre Servat; Marine Wasniewski; Matthieu Gaillard; Christophe Borel; Florence Cliquet
Journal:  BMC Vet Res       Date:  2017-12-13       Impact factor: 2.741

7.  A two-step lyssavirus real-time polymerase chain reaction using degenerate primers with superior sensitivity to the fluorescent antigen test.

Authors:  Vanessa Suin; Florence Nazé; Aurélie Francart; Sophie Lamoral; Stéphane De Craeye; Michael Kalai; Steven Van Gucht
Journal:  Biomed Res Int       Date:  2014-04-15       Impact factor: 3.411

Review 8.  Lyssaviruses and bats: emergence and zoonotic threat.

Authors:  Ashley C Banyard; Jennifer S Evans; Ting Rong Luo; Anthony R Fooks
Journal:  Viruses       Date:  2014-08-04       Impact factor: 5.048

9.  Comparative studies on the genetic, antigenic and pathogenic characteristics of Bokeloh bat lyssavirus.

Authors:  Tobias Nolden; Ashley C Banyard; Stefan Finke; Anthony R Fooks; Dennis Hanke; Dirk Höper; Daniel L Horton; Thomas C Mettenleiter; Thomas Müller; Jens P Teifke; Conrad M Freuling
Journal:  J Gen Virol       Date:  2014-05-14       Impact factor: 3.891

10.  Cross-neutralization of antibodies induced by vaccination with Purified Chick Embryo Cell Vaccine (PCECV) against different Lyssavirus species.

Authors:  Claudius Malerczyk; Conrad Freuling; Dieter Gniel; Alexandra Giesen; Thomas Selhorst; Thomas Müller
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.